HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Sikov Selected Research

Biomarkers (Surrogate Marker)

2/2016Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers.
1/2016Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Sikov Research Topics

Disease

7Neoplasms (Cancer)
02/2016 - 11/2002
5Breast Neoplasms (Breast Cancer)
02/2016 - 09/2005
5Pathologic Complete Response
02/2016 - 09/2005
2Rectal Neoplasms (Rectal Cancer)
06/2017 - 01/2012
1Body Weight (Weight, Body)
09/2015
1Wounds and Injuries (Trauma)
01/2012
1Carcinoma (Carcinomatosis)
11/2002

Drug/Important Bio-Agent (IBA)

3130-nm albumin-bound paclitaxelIBA
02/2016 - 05/2014
3Trastuzumab (Herceptin)FDA Link
02/2016 - 05/2014
3Paclitaxel (Taxol)FDA LinkGeneric
09/2015 - 11/2002
2Biomarkers (Surrogate Marker)IBA
02/2016 - 01/2016
2Bevacizumab (Avastin)FDA Link
02/2016 - 01/2012
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 09/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015 - 09/2005
2Carboplatin (JM8)FDA LinkGeneric
05/2014 - 11/2002
2Fluorouracil (Carac)FDA LinkGeneric
01/2012 - 09/2005
1Capecitabine (Xeloda)FDA Link
06/2017
1Proteins (Proteins, Gene)FDA Link
02/2016
1RNA (Ribonucleic Acid)IBA
02/2016
1Estrogen ReceptorsIBA
09/2015
1Monoclonal AntibodiesIBA
05/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2012
1Leucovorin (Folinic Acid)FDA Link
01/2012

Therapy/Procedure

8Drug Therapy (Chemotherapy)
06/2017 - 11/2002
2Neoadjuvant Therapy
06/2017 - 05/2014
2Adjuvant Chemotherapy
06/2017 - 02/2013
2Therapeutics
02/2016 - 05/2014
1Radiotherapy
06/2017
1Combination Drug Therapy (Combination Chemotherapy)
02/2016
1Biological Therapy
02/2016